ORPHELIA Pharma to support the European paediatric Soft Tissue Sarcoma Study Group winter meeting
Medicines for Europe: 5th Value Added Medicines Conference, 7th November 2023, Brussels
The Medicines for Europe association represent the pharmaceutical companies supplying the largest share of medicines across Europe, it holds its 5th conference on value-added medicines on November 7th, 2023, in Brussels.
Laurent Martin, Orphelia Pharma’s Chief Pharmaceutical Affairs Officer, will attend this conference with the story and market access of Kigabeq, the first pediatric formulation of vigabatrin for the treatment of a rare form of encephalopathic epilepsy: West syndrome.